Patents for A61P 17 - Drugs for dermatological disorders (106,455)
08/2000
08/10/2000WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046215A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000045828A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045804A2 Use of a polyanionic polysaccharide solution for the prevention of abscess formation
08/10/2000WO2000045802A2 Use of (alpha)-d-glucans for promoting cutaneous wound and ulcer healing
08/10/2000WO2000045786A1 Cholesterol sulfate compositions for enhancement of stratum corneum function
08/10/2000WO2000045782A1 TESTOSTERONE-5α-REDUCTASE INHIBITORS, HAIR GROWTH STIMULANT/HAIR NOURISHMENT COMPOSITIONS AND COMPOSITIONS FOR WHITENING COSMETICS
08/10/2000WO2000045774A1 Membrane lipid compositions
08/10/2000WO2000045634A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000WO2000028975A3 Improved chemical process and pharmaceutical formulation
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19904801A1 Agent containing urea, sulfur and Calendula extract, useful for topical treatment of skin disorders, especially neurodermatitis
08/10/2000DE19904352C1 Lipide enthaltender Soja-Extrakt, Verfahren zu dessen Herstellung und pharmazeutische bzw. kosmetische Zusammensetzung sowie deren Verwendung zur Prävention oder Behandlung von trockener Haut Lipids containing soy extract, process for its preparation and to pharmaceutical or cosmetic composition and the use thereof for the prevention or treatment of dry skin
08/10/2000DE19903920A1 Sebozyten, Sebozyten-Zellinie und deren Verwendungen Sebocytes, sebocytes cell line and their uses
08/10/2000DE19903655A1 Hydrogel comprising protein or enzyme bonded to PEG via urea groups, useful as a dressing for wounds and burns
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361572A1 Prevention of abscess formation
08/10/2000CA2361066A1 Inositol derivatives for inhibiting superoxide anion production
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2349703A1 Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
08/10/2000CA2327512A1 Methods for promoting the healing of cutaneous wounds and ulcers using compositions of .alpha.-d-glucans
08/09/2000EP1026150A1 (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same
08/09/2000EP1025898A1 Nanoemulsion from alkoxylated alkenyl succinates or alkoxylated alkenyl succinates of glucose and its cosmetic, dermatologic, ophtalmologic and/or pharmaceutical uses
08/09/2000EP1025860A2 Protein-containing hydrogels
08/09/2000EP1025838A1 A cosmetic composition and a method for reducing the ageing processes of skin
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1024812A1 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
08/09/2000EP1024792A1 Topical antifungal composition
08/09/2000EP1024784A1 Beta-d glucan topical composition
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000EP0641201B1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262625A Use of lactoferin in treatment of allergen induced disorders
08/09/2000CN1262624A Use of colchinol derivatives as vascular damaging agents
08/09/2000CN1262616A Topical application of combination of benzoyl peroxide and second active ingredient
08/09/2000CN1262614A Antimicrobial wipes
08/09/2000CN1262611A Methods for using compositions containing dichlorophenyl imidazoldioxolan to treat sebcrrheic dermatitis, dandruff, psoriasis, and acne, and compositions thereof
08/09/2000CN1262267A 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
08/09/2000CN1262124A Process for preparing liquid medicine to treat dermatopathy
08/09/2000CN1262113A Chinese-medicinal composition for treating acne
08/09/2000CN1262093A Silver foil cosmetics
08/09/2000CN1055243C Spray preparation for burns and scald and its preparation process
08/09/2000CN1055226C Medicine for curing trichomadesis and its preparation method
08/09/2000CN1055225C Marmot oil ointment for burns and scald
08/09/2000CN1055222C Medical ointment for removing necrotic tissue and promoting tissue regeneration
08/08/2000US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099870 Topical applying agent which inhibits danduff
08/08/2000US6099866 Mixture of beeswax, oil and water
08/08/2000CA2185019C Isoxazoline compounds as inhibitors of tnf release
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044863A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
08/03/2000WO2000044862A1 Process of converting rendered triglyceride oil from marine sources into bland, stable oil
08/03/2000WO2000044788A1 Production of tetravalent antibodies
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
08/03/2000WO2000044372A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044342A1 Galenic formulation containing biotin
08/03/2000WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000015179A3 Cosmetic composition
08/03/2000WO2000009551A9 Human chordin-related proteins and polynucleotides encoding them
08/03/2000WO2000009018A9 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO2000006185A3 Methods of using lanreotide, a somatostatin analogue
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO1999062561A3 Gene therapy method
08/03/2000DE19903241A1 Galenische Formulierung Drug formulation
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens